Evaluation of Cortical and Trabecular Bone Structure of the Mandible in Oral Contraceptive Users
Abstract
Objective: Oral contraceptives (OCs) are widely prescribed hormonal agents that may influence bone homeostasis due to their estrogen content. Estrogen is essential for maintaining skeletal integrity, primarily by modulating osteoblast and osteoclast activity. This study aimed to evaluate whether combined oral contraceptive (COC) use affects mandibular bone microarchitecture using fractal dimension (FD) analysis and panoramic mandibular index (PMI) assessments. Methods: A case-control design was employed, analyzing digital panoramic radiographs from 290 women aged 18–50, including 145 COC users and 145 age-matched controls. FD values were determined from three mandibular sites: the condyle, angle, and interdental region. PMI values were also computed. Data were analyzed using SPSS software version 21.0 (IBM Corp., Armonk, NY, USA), p<0.05 was considered significant. Results: There were no statistically significant variations in FD values observed between the COC user group and the control group in the condylar (p=0.183), angular (p=0.603), or interdental (p=0.159) areas. Likewise, there was no significant difference in PMI values between the two groups (p=0.183). Additionally, neither FD nor PMI values were significantly associated with estimated duration of contraceptive use. Conclusion: Based on FD and PMI measurements, the study found no evidence that COC use leads to notable alterations in mandibular bone structure. These results suggest that estrogen-containing contraceptives may not adversely affect jawbone health in premenopausal women.
Keywords
References
- 1. Ampatzis C, Zervoudis S, Iatrakis G, Mastorakos G. Effect of oral contraceptives on bone mineral density. Acta Endocrinol (Buchar) 2022;18:355-360.
- 2. Almstedt Shoepe H, Snow CM. Oral contraceptive use in young women is associated with lower bone mineral density than that of controls. Osteoporosis Int 2005;16:1538-1544.
- 3. Işıklar C, Özçakar N. Long-term health problems in the use of oral contraceptives. TJTFP 2011;2:16-22.
- 4. Hadji P, Colli E, Regidor PA. Bone health in estrogen-free contraception. Osteoporos Int 2019;30:2391-400.
- 5. Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab 2012;23:576-581.
- 6. de Assis ACS, de Oliveira Gamba T, de Moraes MEL, de Moraes LC, Flores IL, de Castro Lopes SLP. Hormone replacement therapy affects mandibular bone architecture in postmenopausal women: a fractal dimension assessment. Rheumatol Orthop Med 2017;1:1-4.
- 7. Scholes D, Hubbard RA, Ichikawa LE, LaCroix AZ, Spangler L, Beasley JM, et al. Oral contraceptive use and bone density in adolescent and young adult women. Contraception 2010;81:35-40.
- 8. Nappi C, Bifulco G, Tommaselli GA, Gargano V, Di Carlo C. Hormonal contraception and bone metabolism: a systematic review. Contraception 2012;86:606-21.
Details
Primary Language
English
Subjects
Oral and Maxillofacial Radiology
Journal Section
Research Article
Publication Date
March 27, 2026
Submission Date
July 31, 2025
Acceptance Date
October 24, 2025
Published in Issue
Year 2026 Volume: 29 Number: 1